Outlook Therapeutics (OTLK) Other Operating Expenses (2018 - 2020)
Outlook Therapeutics' Other Operating Expenses came in at $3.23 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 51.7% from $6.69 million a year earlier and down 25.7% from the prior quarter.
Outlook Therapeutics (OTLK) Other Operating Expenses (2018 - 2020) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Outlook Therapeutics reported Other Operating Expenses of $16.25 million, down 51.2% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $25.82 million, down 38.2% from FY2024.
- Other Operating Expenses carries a five-year compound annual growth rate of -0.8% (FY2020 to FY2025).
- Going back by fiscal year, Other Operating Expenses was $41.76 million in FY2024 (+57.9%), $26.45 million in FY2023 (-37.5%), $42.33 million in FY2022 (+8.7%) and $38.96 million in FY2021 (+45.0%).
- The fiscal Q3 2026 figure represents the lowest quarterly Other Operating Expenses since fiscal Q2 2023.
- Year-over-year, Other Operating Expenses has declined for six consecutive quarters, with an average decline of 2.0% over the last eight quarters.
- The fastest year-over-year change in Other Operating Expenses over five years came in fiscal Q4 2024 (growth of 153.3%), and the weakest in fiscal Q2 2023 (a decline of 95.5%).
- Business Quant data shows OTLK's Other Operating Expenses at $4.35 million (Q2 2026), $3.6 million (Q1 2026) and $5.06 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Outlook Therapeutics | 62.90 Mn | 27.15 Mn | -8,265.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 104,296.00 |
| Mar 31, 2020 | 423,328.00 |
| Sep 30, 2019 | 8.31 Mn |
| Jun 30, 2019 | 50,927.00 |
| Mar 31, 2019 | 561,735.00 |
| Dec 31, 2018 | 2.35 Mn |
Outlook Therapeutics Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();